154 related articles for article (PubMed ID: 26511267)
1. Is It Time to Centralize Ovarian Cancer Care in the United States?
Cowan RA; O'Cearbhaill RE; Gardner GJ; Levine DA; Roche KL; Sonoda Y; Zivanovic O; Tew WP; Sala E; Lakhman Y; Vargas Alvarez HA; Sarasohn DM; Mironov S; Abu-Rustum NR; Chi DS
Ann Surg Oncol; 2016 Mar; 23(3):989-93. PubMed ID: 26511267
[TBL] [Abstract][Full Text] [Related]
2. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
3. Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention.
Dottino JA; Cliby WA; Myers ER; Bristow RE; Havrilesky LJ
Gynecol Oncol; 2015 Sep; 138(3):694-9. PubMed ID: 26072441
[TBL] [Abstract][Full Text] [Related]
4. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer.
Aviki EM; Lavery JA; Roche KL; Cowan R; Dessources K; Basaran D; Green AK; Aghajanian CA; O'Cearbhaill R; Jewell EL; Leitao MM; Gardner GJ; Abu-Rustum NR; Sabbatini P; Bach PB
Gynecol Oncol; 2020 Nov; 159(2):418-425. PubMed ID: 32814642
[TBL] [Abstract][Full Text] [Related]
5. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
[TBL] [Abstract][Full Text] [Related]
6. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
7. Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma.
Idrees JJ; Merath K; Gani F; Bagante F; Mehta R; Beal E; Cloyd JM; Pawlik TM
HPB (Oxford); 2019 Aug; 21(8):981-989. PubMed ID: 30591307
[TBL] [Abstract][Full Text] [Related]
8. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
Bristow RE; Chang J; Ziogas A; Anton-Culver H
Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
[TBL] [Abstract][Full Text] [Related]
9. Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.
Ore RM; Chen Q; DeSimone CP; Miller RW; Baldwin LA; van Nagell JR; Huang B; Tucker TC; Johnson MS; Fredericks TI; Ueland FR
South Med J; 2018 Jun; 111(6):333-341. PubMed ID: 29863220
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.
Cliby WA; Powell MA; Al-Hammadi N; Chen L; Philip Miller J; Roland PY; Mutch DG; Bristow RE
Gynecol Oncol; 2015 Jan; 136(1):11-7. PubMed ID: 25449311
[TBL] [Abstract][Full Text] [Related]
11. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS
Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811
[TBL] [Abstract][Full Text] [Related]
12. New world order(s): healthcare metrics, international borders, and gravitational waves.
Tewari KS
Gynecol Oncol; 2014 May; 133(2):139-41. PubMed ID: 24773670
[No Abstract] [Full Text] [Related]
13. The National Comprehensive Cancer Network: present and future directions.
McGivney WT
Cancer; 1998 May; 82(10 Suppl):2057-60. PubMed ID: 9587107
[TBL] [Abstract][Full Text] [Related]
14. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
15. Patient-centered research priorities in ovarian cancer: A systematic review of potential determinants of guideline care.
Pozzar RA; Berry DL
Gynecol Oncol; 2017 Dec; 147(3):714-722. PubMed ID: 29029759
[TBL] [Abstract][Full Text] [Related]
16. Failure to rescue as a source of variation in hospital mortality for ovarian cancer.
Wright JD; Herzog TJ; Siddiq Z; Arend R; Neugut AI; Burke WM; Lewin SN; Ananth CV; Hershman DL
J Clin Oncol; 2012 Nov; 30(32):3976-82. PubMed ID: 23032619
[TBL] [Abstract][Full Text] [Related]
17. Organisation and quality of primary surgical intervention for ovarian cancer in Denmark.
Marx C; Bendixen A; Høgdall C; Ottosen C; Kehlet H; Ottesen B
Acta Obstet Gynecol Scand; 2007; 86(12):1496-502. PubMed ID: 17851818
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of "threshold" in the management of ovarian cancer: A review of the literature].
Seror J; Guillot E; Genin AS; Hequet D; Pouget N; Dubot C; Rouzier R
Bull Cancer; 2016 Jun; 103(6):513-23. PubMed ID: 27238445
[TBL] [Abstract][Full Text] [Related]
19. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer.
Du Bois A; Rochon J; Lamparter C; Pfisterer J;
Int J Gynecol Cancer; 2005; 15(2):183-91. PubMed ID: 15823098
[TBL] [Abstract][Full Text] [Related]
20. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States.
Harlan LC; Clegg LX; Trimble EL
J Clin Oncol; 2003 Sep; 21(18):3488-94. PubMed ID: 12972525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
